Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Classement en actions #19054
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Prix de l'action
$1.27
Capitalisation boursière
$176.31M
Changement (1 jour)
5.57%
Changement (1 an)
29.36%
Pays
TW
Échange Medigen Biotechnology Corp. (3176)

Catégorie

Historique du prix de l'action pour Medigen Biotechnology Corp. (3176)
Prix de clôture le plus élevé : $1.12 le 2026-08-01

Prix de clôture le plus bas : $1.26 le 2007-12-01
Historique du prix de l'action de Medigen Biotechnology Corp. de 2007 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.89%
2025 -0.53%
2024 -32.95%
2023 27.93%
2022 -41.27%
2021 -4.41%
2020 1.18%
2019 52.77%
2018 15.52%
2017 -52.31%
2016 -10.15%
2015 -44.93%
2014 -20.99%
2013 7.34%
2012 409.30%
2011 131.95%
2010 8.02%
2009 42.20%
2008 -74.41%
2007 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$549.38 41.89%
US
$1.06K 48.99%
NL
$121.62 -12.98%
AU
$145.86 489.81%
US
$764.47 6.25%
CH